These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38632341)
1. Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model. Bastian JLD; Zeuschner P; Stöckle M; Junker K; Linxweiler J Sci Rep; 2024 Apr; 14(1):8835. PubMed ID: 38632341 [TBL] [Abstract][Full Text] [Related]
2. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases. Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953 [TBL] [Abstract][Full Text] [Related]
3. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464 [TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model. Linxweiler J; Hajili T; Körbel C; Berchem C; Zeuschner P; Müller A; Stöckle M; Menger MD; Junker K; Saar M Sci Rep; 2020 Jul; 10(1):12575. PubMed ID: 32724081 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer. Linxweiler J; Hammer M; Muhs S; Kohn M; Pryalukhin A; Veith C; Bohle RM; Stöckle M; Junker K; Saar M J Cancer Res Clin Oncol; 2019 Mar; 145(3):551-559. PubMed ID: 30474758 [TBL] [Abstract][Full Text] [Related]
6. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059 [TBL] [Abstract][Full Text] [Related]
7. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511 [TBL] [Abstract][Full Text] [Related]
8. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502 [TBL] [Abstract][Full Text] [Related]
9. High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP. Wang X; An Z; Geller J; Hoffman RM Prostate; 1999 May; 39(3):182-6. PubMed ID: 10334107 [TBL] [Abstract][Full Text] [Related]
10. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related]
11. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. An Z; Wang X; Geller J; Moossa AR; Hoffman RM Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844 [TBL] [Abstract][Full Text] [Related]
12. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851 [TBL] [Abstract][Full Text] [Related]
13. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells. Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928 [TBL] [Abstract][Full Text] [Related]
14. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827 [TBL] [Abstract][Full Text] [Related]
15. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice. Zhao Z; He J; Kang R; Zhao S; Liu L; Li F Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693 [TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture. Eder T; Weber A; Neuwirt H; Grünbacher G; Ploner C; Klocker H; Sampson N; Eder IE Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598125 [TBL] [Abstract][Full Text] [Related]
17. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Wang Y; Xue H; Cutz JC; Bayani J; Mawji NR; Chen WG; Goetz LJ; Hayward SW; Sadar MD; Gilks CB; Gout PW; Squire JA; Cunha GR; Wang YZ Lab Invest; 2005 Nov; 85(11):1392-404. PubMed ID: 16155594 [TBL] [Abstract][Full Text] [Related]
18. Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features. Takagi A; Watanabe M; Ishii Y; Morita J; Hirokawa Y; Matsuzaki T; Shiraishi T Anticancer Res; 2007; 27(1A):45-53. PubMed ID: 17352215 [TBL] [Abstract][Full Text] [Related]
19. Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein. Maeda H; Segawa T; Kamoto T; Yoshida H; Kakizuka A; Ogawa O; Kakehi Y Prostate; 2000 Dec; 45(4):335-40. PubMed ID: 11102959 [TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]